EUCAST Technical Note on Candida and micafungin, anidulafungin and fluconazole

Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America

Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191 · see citing works

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients

Cornely, O. A., Bassetti, M., Calandra, T., Garbino, J., Kullberg, B. J., Lortholary, O., Meersseman, W., Akova, M., Arendrup, M. C., Arikan-Akdagli, S., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12039 · Cited by 1,217 · see citing works

Anidulafungin versus Fluconazole for Invasive Candidiasis

Reboli, A. C., Rotstein, C., Pappas, P. G., Chapman, S. W., Kett, D. H., Kumar, D., Betts, R., Wible, M., Goldstein, B. P., Schranz, J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066906 · Cited by 894 · see citing works

Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial

Kuse, E.-R., Chetchotisakd, P., da Cunha, C. A., Ruhnke, M., Barrios, C., Raghunadharao, D., Sekhon, J. S., Freire, A., Ramasubramanian, V., Demeyer, I., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60605-9 · Cited by 692 · see citing works

Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis

Pappas, P. G., Rotstein, C. M. F., Betts, R. F., Nucci, M., Talwar, D., De Waele, J. J., Vazquez, J. A., Dupont, B. F., Horn, D. L., Ostrosky-Zeichner, L., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/520980 · Cited by 638 · see citing works

ESCMID guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)

Ullmann, A. J., Akova, M., Herbrecht, R., Viscoli, C., Arendrup, M. C., Arikan-Akdagli, S., Bassetti, M., Bille, J., Calandra, T., Castagnola, E., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12041 · Cited by 334 · see citing works

<i>In Vivo</i> Comparison of the Pharmacodynamic Targets for Echinocandin Drugs against <i>Candida</i> Species

Andes, D., Diekema, D. J., Pfaller, M. A., Bohrmuller, J., Marchillo, K., & Lepak, A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01584-09 · Cited by 226 · see citing works

Micafungin Versus Liposomal Amphotericin B for Pediatric Patients With Invasive Candidiasis

Queiroz‐Telles, F., Berezin, E. N., Leverger, G., Freire, A., van der Vyver, A., Chotpitayasunondh, T., Konja, J., Diekmann-Berndt, H., Koblinger, S., Groll, A. H., et al. (2008) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31817275e6 · Cited by 210 · see citing works

Breakthrough invasive candidiasis in patients on micafungin.

Pfeiffer, C. D., Garcia-Effron, G., Zaas, A. K., Perfect, J. R., Perlin, D. S., & Alexander, B. D. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02390-09 · Cited by 196 · see citing works

In Vivo Pathogenicity of Eight Medically Relevant Candida Species in an Animal Model

Arendrup, M. C., Horn, T. D., & Møller, J. K. (2002) · Infection · doi:10.1007/s15010-002-2131-0 · Cited by 167 · see citing works

A randomized, double blind, comparative trial of micafungin (FK463) vs. fluconazole for the treatment of oesophageal candidiasis

Wet, N. T. E. D., Bester, A. J., Viljoen, J., Filho, F. A. B. D. O., Suleiman, J. M. A. H., Ticona, E., Llanos, E. A., Fisco, C., Lau, W. M., & Buell, D. N. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02427.x · Cited by 144 · see citing works

Use of Pharmacokinetic-Pharmacodynamic Analyses To Optimize Therapy with the Systemic Antifungal Micafungin for Invasive Candidiasis or Candidemia

Andes, D. R., Ambrose, P. G., Hammel, J., Wart, S. A. V., Iyer, V., Reynolds, D. K., Buell, D. N., Kovanda, L. L., & Bhavnani, S. M. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01430-10 · Cited by 119 · see citing works

Differential <i>In Vivo</i> Activities of Anidulafungin, Caspofungin, and Micafungin against Candida glabrata Isolates with and without <i>FKS</i> Resistance Mutations

Arendrup, M. C., Perlin, D. S., Jensen, R. H., Howard, S. J., Goodwin, J., & Hope, W. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06369-11 · Cited by 117 · see citing works

EUCAST Technical Note on fluconazole

* (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01899.x · Cited by 94 · see citing works

Risk Factors for Fluconazole-Resistant Candida glabrata Bloodstream Infections

Lee, I., Fishman, N. O., Zaoutis, T. E., Morales, K. H., Weiner, M. G., Synnestvedt, M. B., Nachamkin, I., & Lautenbach, E. (2009) · Archives of Internal Medicine · doi:10.1001/archinte.169.4.379 · Cited by 82 · see citing works

Microarray and Molecular Analyses of the Azole Resistance Mechanism in <i>Candida glabrata</i> Oropharyngeal Isolates

Tsai, H.-F., Sammons, L. R., Zhang, X., Suffis, S. D., Su, Q., Myers, T. G., Marr, K. A., & Bennett, J. E. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00535-10 · Cited by 80 · see citing works

EUCAST technical note on anidulafungin

Arendrup, M. C., Rodriguez-Tudela, J. L., Lass‐Flörl, C., Cuenca‐Estrella, M., Donnelly, J. P., & Hope, W. W. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03647.x · Cited by 60 · see citing works

Disseminated Candidiasis Caused by Candida albicans with Amino Acid Substitutions in Fks1 at Position Ser645 Cannot Be Successfully Treated with Micafungin

Slater, J. L., Howard, S. J., Sharp, J., Goodwin, J., Gregson, L., Alastruey‐Izquierdo, A., Arendrup, M. C., Warn, P. A., Perlin, D. S., & Hope, W. W. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01686-10 · Cited by 52 · see citing works

Pharmacodynamics of echinocandins against Candida glabrata: requirement for dosage escalation to achieve maximal antifungal activity in neutropenic hosts

Howard, S. J., Livermore, J., Sharp, A., Goodwin, J., Gregson, L., Alastruey-Izquierdo, A., Perlin, D. S., Warn, P. A., & Hope, W. W. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00621-11 · Cited by 48 · see citing works

National Surveillance of Fungemia in Denmark 2010-11

Arendrup, M. C., Dzajic, E., Johansen, H. K., Kjældgaard, P., Knudsen, J. D., Kristensen, L., Leitz, C., Lemming, L. E., Nielsen, L. B., Olesen, B. R. S., et al. (2012) · University of Southern Denmark Research Portal (University of Southern Denmark) · Cited by 14 · see citing works

Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment

Arendrup, M. C., & Patterson, T. F. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix131 · Cited by 707 · see citing works

Emerging Threats in Antifungal-Resistant Fungal Pathogens

Sanglard, D. (2016) · Frontiers in Medicine · doi:10.3389/fmed.2016.00011 · Cited by 420 · see citing works

Antifungal Susceptibility Testing: Current Approaches

Berkow, E. L., Lockhart, S. R., & Ostrosky‐Zeichner, L. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00069-19 · Cited by 394 · see citing works

Echinocandin resistance: an emerging clinical problem?

Arendrup, M. C., & Perlin, D. S. (2014) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000111 · Cited by 299 · see citing works

How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST)

Arendrup, M. C., Friberg, N., Ma, M., Kahlmeter, G., Meletiadis, J., Guinea, J., Arendrup, M., Meletiadis, J., Guinea, J., Friberg, N., et al. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.06.007 · Cited by 248 · see citing works

Update on antifungal resistance in Aspergillus and Candida

Arendrup, M. C. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12513 · Cited by 240 · see citing works

Emerging multidrug-resistant Candida species

Colombo, A. L., Júnior, J. N. D. A., & Guinea, J. (2017) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000411 · Cited by 177 · see citing works

Breakpoints for antifungal agents: An update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp.

Arendrup, M. C., Cuenca-Estrella, M., Lass-Flörl, C., & Hope, W. W. (2013) · Drug Resistance Updates · doi:10.1016/j.drup.2014.01.001 · Cited by 129 · see citing works

Update from a 12-Year Nationwide Fungemia Surveillance: Increasing Intrinsic and Acquired Resistance Causes Concern

Astvad, K. M. T., Johansen, H. K., Røder, B. L., Rosenvinge, F. S., Knudsen, J. D., Lemming, L., Schønheyder, H. C., Hare, R. K., Kristensen, L., Nielsen, L., et al. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01564-17 · Cited by 125 · see citing works

Molecular basis of antifungal drug resistance in yeasts

Morio, F., Jensen, R. H., Le Pape, P., & Arendrup, M. C. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.05.012 · Cited by 114 · see citing works

Stepwise emergence of azole, echinocandin and amphotericin B multidrug resistance<i>in vivo</i>in<i>Candida albicans</i>orchestrated by multiple genetic alterations

Jensen, R. H., Astvad, K. M. T., Silva, L. V., Sanglard, D., Jørgensen, R., Nielsen, K. F., Mathiasen, E. G., Doroudian, G., Perlin, D. S., & Arendrup, M. C. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv140 · Cited by 95 · see citing works

Multicenter Study of Method-Dependent Epidemiological Cutoff Values for Detection of Resistance in Candida spp. and Aspergillus spp. to Amphotericin B and Echinocandins for the Etest Agar Diffusion Method

Espinel‐Ingroff, A., Arendrup, M. C., Cantón, R., Córdoba, S. B., Dannaoui, É., García‐Rodríguez, J., González, G. M., Govender, N. P., Martín‐Mazuelos, E., Lackner, M., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01792-16 · Cited by 90 · see citing works

Posttreatment Antifungal Resistance among Colonizing Candida Isolates in Candidemia Patients: Results from a Systematic Multicenter Study

Jensen, R. H., Johansen, H. K., Søes, L. M., Lemming, L. E., Rosenvinge, F. S., Nielsen, L., Olesen, B., Kristensen, L., Dzajic, E., Astvad, K. M. T., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01763-15 · Cited by 77 · see citing works

Positions and Numbers of <i>FKS</i> Mutations in Candida albicans Selectively Influence <i>In Vitro</i> and <i>In Vivo</i> Susceptibilities to Echinocandin Treatment

Lackner, M., Tscherner, M., Schaller, M., Kuchler, K., Mair, C., Sartori, B., Istel, F., Arendrup, M. C., & Lass-Flörl, C. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00123-14 · Cited by 67 · see citing works

Multicentre validation of 4-well azole agar plates as a screening method for detection of clinically relevant azole-resistant Aspergillus fumigatus

Arendrup, M. C., Verweij, P. E., Mouton, J. W., Lagrou, K., & Meletiadis, J. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx319 · Cited by 60 · see citing works

Detection and identification of antimicrobial-resistant Salmonella in raw beef at Wolaita Sodo municipal abattoir, Southern Ethiopia

Wabeto, W., Abraham, Y., & Anjulo, A. A. (2017) · Journal of Health Population and Nutrition · doi:10.1186/s41043-017-0131-z · Cited by 56 · see citing works

PK-PD Integration Modeling and Cutoff Value of Florfenicol against Streptococcus suis in Pigs

Lei, Z., Liu, Q., Yang, S., Yang, B., Khaliq, H., Li, K., Ahmed, S., Sajid, A., Zhang, B., Pin, C., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00002 · Cited by 40 · see citing works

Candida vertebral osteomyelitis (CVO) 28 cases from a 10-year retrospective study in France

Richaud, C., LASTOURS, V. D., Panhard, X., Petrover, D., Fantin, B., & Lefort, A. (2017) · Medicine · doi:10.1097/md.0000000000007525 · Cited by 36 · see citing works

Antimicrobial resistance of commensal Enterococcus faecalis and Enterococcus faecium from food-producing animals in Russia

Makarov, D. A., Ivanova, O. E., Pomazkova, A. V., Egoreva, M. A., Прасолова, О. В., Lenev, S. V., Gergel, M. A., Bukova, N. K., & Karabanov, S. Y. (2022) · Veterinary World · doi:10.14202/vetworld.2022.611-621 · Cited by 32 · see citing works

Susceptibility to echinocandins of Candida spp. strains isolated in Italy assessed by European Committee for Antimicrobial Susceptibility Testing and Clinical Laboratory Standards Institute broth microdilution methods

Montagna, M. T., Lovero, G., Coretti, C., Martinelli, D., Giglio, O. D., Iatta, R., Balbino, S., Rosato, A., & Caggiano, G. (2015) · BMC Microbiology · doi:10.1186/s12866-015-0442-4 · Cited by 32 · see citing works

Results from the Survey of Antibiotic Resistance (SOAR) 2011–13 in Turkey

Söyletir, G., Altınkanat, G., Gür, D., Altun, B., Tünger, A., Aydemir, Ş., Kayacan, Ç., Aktaş, Z., Günaydın, M., Karadağ, A., et al. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw075 · Cited by 30 · see citing works

Molecular Identification and Echinocandin Susceptibility of Candida parapsilosis Complex Bloodstream Isolates in Italy, 2007–2014

Lovero, G., Borghi, E., Balbino, S., Cirasola, D., Giglio, O. D., Perdoni, F., Caggiano, G., Morace, G., & Montagna, M. T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150218 · Cited by 29 · see citing works

Epidemiology of Echinocandin Resistance in Candida

Grossman, N. T., Chiller, T. M., & Lockhart, S. R. (2014) · Current Fungal Infection Reports · doi:10.1007/s12281-014-0209-7 · Cited by 28 · see citing works

Echinocandin Failure Case Due to a Previously Unreported FKS1 Mutation in Candida krusei

Hare, R. K., Justesen, U. S., Rewes, A., Perlin, D. S., & Arendrup, M. C. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02367-14 · Cited by 28 · see citing works

Can yeast isolation be predicted in complicated secondary non-postoperative intra-abdominal infections?

Dupont, H., Guilbart, M., Ntouba, A., Perquin, M., Petiot, S., Regimbeau, J., Chouaki, T., Mahjoub, Y., & Zogheib, E. H. (2015) · Critical Care · doi:10.1186/s13054-015-0790-3 · Cited by 28 · see citing works

New approaches for antifungal susceptibility testing

Sanguinetti, M., & Posteraro, B. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.03.025 · Cited by 27 · see citing works

Anidulafungin for the treatment of candidaemia caused byCandida parapsilosis: Analysis of pooled data from six prospective clinical studies

Kontoyiannis, D. P., Bassetti, M., Nucci, M., Capparella, M. R., Yan, J. L., Aram, J. A., & Hogan, P. A. (2017) · Mycoses · doi:10.1111/myc.12641 · Cited by 22 · see citing works

Species distribution and antifungal susceptibility profile of Candida isolates from blood and other normally sterile foci from pediatric ICU patients in Tehran, Iran

Mirhendi, H., Charsizadeh, A., Eshaghi, H., Nikmanesh, B., & Arendrup, M. C. (2019) · Medical Mycology · doi:10.1093/mmy/myz047 · Cited by 21 · see citing works

Antifungal susceptibility testing inCandidaspecies: current methods and promising new tools for shortening the turnaround time

Knabl, L., & Lass‐Flörl, C. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1760841 · Cited by 16 · see citing works

Pharmacokinetics of Micafungin in Critically Ill Patients

Gastine, S., Lanckohr, C., Blessou, M., Horn, D., Fobker, M., Bause, D., Hempel, G., & Ellger, B. (2019) · Scientific Reports · doi:10.1038/s41598-019-53093-6 · Cited by 15 · see citing works

Invasive Fungal Breakthrough Infections under Targeted Echinocandin Prophylaxis in High-Risk Liver Transplant Recipients

Breitkopf, R., Treml, B., Senoner, T., Bukumirić, Z., & Rajšić, S. (2023) · Journal of Fungi · doi:10.3390/jof9020272 · Cited by 13 · see citing works

The association between treatment appropriateness according to EUCAST and CLSI breakpoints and mortality among patients with candidemia: a retrospective observational study

Ghanem‐Zoubi, N., Zorbavel, D., Khoury, J., Geffen, Y., Qasum, M., Predescu, S., & Paul, M. (2018) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-018-3389-1 · Cited by 12 · see citing works

Multicenter Comparison of the Etest and EUCAST Methods for Antifungal Susceptibility Testing of Candida Isolates to Micafungin

Bougnoux, M., Dannaoui, É., Accoceberry, I., Angoulvant, A., Bailly, E., Botterel, F., Chevrier, S., Chouaki, T., Cornet, M., Dalle, F., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00630-16 · Cited by 10 · see citing works

In Vitro Antifungal Susceptibility of Candida glabrata to Caspofungin and the Presence of FKS Mutations Correlate with Treatment Response in an Immunocompromised Murine Model of Invasive Infection

Fernández‐Silva, F., Lackner, M., Capilla, J., Mayayo, E., Sutton, D. A., Castanheira, M., Fothergill, A. W., Lass‐Flörl, C., & Guarro, J. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02666-13 · Cited by 10 · see citing works

Mechanisms of Drug Resistance in Candida albicans

Sanglard, D. (2017) · Springer eBooks · doi:10.1007/978-3-319-50409-4_15 · Cited by 7 · see citing works

Multidrug- and Cross-Resistant Candida: the Looming Threat

Lackner, M., Martín‐Vicente, A., & Lass‐Flörl, C. (2014) · Current Fungal Infection Reports · doi:10.1007/s12281-014-0210-1 · Cited by 4 · see citing works

Clinical pharmacology and practical aspects of isavuconazole use

Veselov, A. V. (2023) · Clinical Microbiology and Antimicrobial Chemotherapy · doi:10.36488/cmac.2023.4.379-394 · Cited by 3 · see citing works

Computational molecular docking and simulation-based prediction of natural compounds from nyctanthes arbor-tristis as potential antifungal agents

Akhtar, S., Ahmad, V., Aatif, M., & Jamal, Q. M. S. (2026) · Journal of King Saud University - Science · doi:10.25259/jksus_1667_2025 · Cited by 2 · see citing works

Strategien bei Versagen einer antimykotischen Therapie auf Intensivstation

Arens, C., Bernhard, M., Koch, C., Heininger, A., Störzinger, D., Hoppe‐Tichy, T., Hecker, M., Grabein, B., Weigand, M. A., & Lichtenstern, C. (2015) · Der Anaesthesist · doi:10.1007/s00101-015-0072-0 · Cited by 1 · see citing works

Hot Topics in Antifungal Susceptibility Testing: a New Drug, a Bad Bug, Sweeping Caspofungin Testing under the Rug, and Solving the Epidemiological Cutoff Value Shrug

Lockhart, S. R., & Berkow, E. L. (2016) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2016.06.001 · Cited by 1 · see citing works

Study of Molds in Post COVID -19 Patients: An experience from Tertiary Care Centre

Gade, N. (2022) · doi:10.37191/mapsci-jidm-1(1)-007 · Cited by 1 · see citing works

Estudo químico e biológico das flores de Cassia bakeriana Craib

Silva, F. (2021) · doi:10.14393/ufu.di.2021.356

Chronic stress and vitamin B₁₂ deficiency as potential risk factors for recurrent vulvovaginal candidiasis: A comparative clinical study

Shnawa, B. H., Jalil, P. J., Hassan, A., Wsu, K. W., Muksy, R., & Ahmed, M. H. (2026) · Advances in Integrative Medicine · doi:10.1016/j.aimed.2026.100728

How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST)

Arendrup, M. C., Friberg, N., Ma, M., Kahlmeter, G., Meletiadis, J., Guinea, J., Arendrup, M., Meletiadis, J., Guinea, J., Friberg, N., et al. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.06.007 · Cited by 248 · see citing works

EUCAST technical note on anidulafungin

Arendrup, M. C., Rodriguez-Tudela, J. L., Lass‐Flörl, C., Cuenca‐Estrella, M., Donnelly, J. P., & Hope, W. W. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03647.x · Cited by 60 · see citing works

EUCAST technical note on posaconazole

Arendrup, M. C., Cuenca-Estrella, M., Donnelly, J. P., Hope, W., Lass-Flörl, C., & Rodriguez-Tudela, J.-L. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03646.x · Cited by 34 · see citing works

Correlation of MIC with Outcome for <i>Candida</i> Species Tested against Caspofungin, Anidulafungin, and Micafungin: Analysis and Proposal for Interpretive MIC Breakpoints

Pfaller, M. A., Diekema, D. J., Ostrosky-Zeichner, L., Rex, J. H., Alexander, B. D., Andes, D., Brown, S. D., Chaturvedi, V., Ghannoum, M. A., Knapp, C. C., et al. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00566-08 · Cited by 250 · see citing works

EUCAST breakpoints for antifungals

Rodrı́guez-Tudela, J. L., Arendrup, M. C., Cuenca‐Estrella, M., Donnelly, J. P., & Lass‐Flörl, C. (2010) · Drug News & Perspectives · doi:10.1358/dnp.2010.23.2.1400855 · Cited by 41 · see citing works